BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, July 14, 2026
Home
»
Newsletters
» BioWorld
BioWorld
May 3, 2007
View Archived Issues
Array Raises $91M Publicly For Cancer, Inflammation Programs
Array BioPharma Inc. raised $91 million in a public offering of stock, money that will be used to fund development of its broad, early stage pipeline of small-molecule drug candidates for cancer and inflammatory diseases. (BioWorld Today)
Read More
Varying FOB Proposals Seem To Signal Compromise In The Works
Read More
Specific Starvation Gene Joins Sirtuins As Longevity Target
Read More
NeurogesX Lowers Share Price Again, Brings In $44M In IPO
Read More
AVI, Ercole Join Technologies To Tackle DMD, Thalassemia
Read More
Immunomedics Raises $24M For Anticancer Antibodies
Read More
Other News To Note
Read More
Clinic Roundup
Read More
